Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03248479
Title Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Forty Seven, Inc.

myelodysplastic syndrome

acute myeloid leukemia


Azacitidine + Hu5F9-G4


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.